Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial
2024; Lippincott Williams & Wilkins; Volume: 42; Issue: 14 Linguagem: Inglês
10.1200/jco.23.01687
ISSN1527-7755
AutoresVincent Camus, Catherine Thiéblemont, Philippe Gaulard, Morgane Cheminant, Olivier Casasnovas, Loïc Ysebaert, Gandhi Damaj, Stéphanie Guidez, Gian Matteo Pica, Won Seog Kim, Soon Thye Lim, Marc André, Norma C. Gutiérrez, María Jesús Peñarrubia, Philipp B. Staber, Judith Trotman, Andreas Hüttmann, Vittorio Stefoni, Alessandra Tucci, Patrick Fogarty, H. Farhat, Julie Abraham, Wajed Abarah, Fatiha Belmecheri, Vincent Ribrag, Marie‐Hélène Delfau‐Larue, Anne‐Ségolène Cottereau, Emmanuel Itti, Ju Li, Richard Delarue, Laurence de Leval, Franck Morschhauser, Emmanuel Bachy,
Tópico(s)Viral-associated cancers and disorders
ResumoJCO
Referência(s)